Germany based joimax, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, has announced the full registration of all its products for India, one of the fastest growing endoscopic spine surgery markets worldwide.

The Indian registration includes all joimax Class II and III, as well as Class I instruments, which were approved in 2023. Now, the Indian health community has access to all the latest spinal endoscopic technologies invented, developed and manufactured by joimax.

“Earlier this year, joimax received its CE MDR approvals, granted by TÜV-South, an important step for marketing our existing products under the new European regulation, which opened a backlog of products to India,” states joimax Founder and CEO Wolfgang Ries. “We’re already active in more than 60 countries. These partners are eager to launch the newest joimax treatment technologies.”